Article

A novel role for the HLH protein Inhibitor of Differentiation 4 (ID4) in the DNA damage response in basal-like breast cancer

2018-03-14

Abstract excerpt

Basal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of the molecular underpinnings of this disease is essential to the development of personalised therapeutic strategies. Inhibitor of Differentiation 4 (ID4) is a helix-loop-helix transcriptional regulator r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c91feb6f-8738-5a61-8944-a633faab9236
DOI: 10.1101/281196

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A novel role for the HLH protein Inhibitor of Differentiation 4 (ID4) in the DNA damage response in basal-like breast cancerDOI 10.1101/281196Read

Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancerSemantic proximity Read

ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancerSemantic proximity Read

Co-regulator activity of Mediator of DNA Damage Checkpoint 1 (MDC1) is associated with DNA repair dysfunction and PARP inhibitor sensitivity in lobular carcinoma of the breastSemantic proximity Read

Exploring ID4 as a Driver of Aggression and a Therapeutic Target in Triple-Negative Breast CancerSemantic proximity Read

The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesisSemantic proximity Read

Mediator of DNA damage checkpoint 1 (MDC1) is a novel estrogen receptor co-regulator in invasive lobular carcinoma of the breastSemantic proximity Read

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.Semantic proximity Read

Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Semantic proximity Read

BRD4 and Cancer: going beyond transcriptional regulationSemantic proximity Read

ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesisSemantic proximity Read

Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivitySemantic proximity Read

Systematic analysis of ZDHHC9 as a potential prognostic and immunotherapy biomarker in breast cancerSemantic proximity Read